Scientific advances

As part of the more recent scientific focus in the treatment of cancer, known as immunotherapy, we are pleased to share our latest publication showing the preliminary results of a pilot study conducted by Dr. Convit based on his proposal documented in 2006 of a personalized vaccine for breast cancer. This is part of the Foundation's efforts to preserve and continue Dr. Convit's visionary work towards an immunotherapeutic treatment for cancer.

Article: Autologous tumor lysate/Bacillus Calmette-Guérin immunotherapy as an adjuvant to conventional breast cancer therapy Journal: Clinical and Translational Oncology

We will continue to inform to the community regarding our progress with these scientific studies on cancer immunotherapy.